Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: Characteristic features of the patients at risk of encapsulating peritoneal sclerosis

Clinical and Experimental Nephrology

Volumn 9, Issue 4, 2005, Pages 315-319

  Otsuka, Yasushi ^a   Nakayama, Masaaki ^a   Ikeda, Masato ^a   Sherif, Ali M ^a   Yokoyama, Keitaro ^a   Yamamoto, Hiroyasu ^a   Kawaguchi, Yoshindo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA125; Encapsulating peritoneal sclerosis (EPS); High transport state; Peritoneal dialysis (PD); Post PD; Risk factor

Indexed keywords

ANTIBIOTIC AGENT; CA 125 ANTIGEN;

ADULT; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; DIALYSATE; ENCAPSULATING PERITONEAL SCLEROSIS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MALE; PERITONEAL DISEASE; PERITONEUM; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL;

CA-125 ANTIGEN; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERITONITIS; RECOVERY OF FUNCTION; RENAL DIALYSIS; RISK FACTORS; SCLEROSIS;

EID: 29144483938     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-005-0384-5     Document Type: Article

References (28)

1. VC Gandhi HM Humayan TS Ing JT Daugirdas WP Geis JE Hano 1980 Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Intern Med 140 1201 3
2. Y Nomoto Y Kawaguchi H Kubo H Hirano S Sakai K Kurokawa 1996 Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group Am J Kidney Dis 28 420 7
3. H Kawanishi Y Kawaguchi H Fukui S Hara A Imada H Kubo 2004 Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study Am J Kidney Dis 44 729 37
4. RJ Rigby CM Hawley 1998 Sclerosing peritonitis: the experience in Australia Nephrol Dial Transplant 13 154 9
5. M Nakayama H Yamamoto H Terawaki K Ooi T Kamijyou K Yokoyama 2000 Longitudinal changes of peritoneal permeability after withdrawal from long-term CAPD treatment. A preliminary study to explore the peritoneal pathophysiology after CAPD treatment (in Japanese) J Jpn Soc Dial Ther 33 1137 42
6. S Homma Y Masunaga M Kurosu M Inoue T Sakurai Y Asano 2002 Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis Perit Dial Int 22 178 83
7. Y Kawaguchi H Kawanishi S Mujais N Topley DG Oreopoulos 2000 Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis Perit Dial Int 20 Suppl 4 S43 55
8. AA Sanusi MM Zweers JJ Weening DR de Waart DG Struijk RT Krediet 2001 Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis Perit Dial Int 21 495 500
9. M Numata M Nakayame S Nimura M Kawakami B Lindholm Y Kawaguchi 2003 Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate Perit Dial Int 23 116 22
10. S Combet P Miyata T Moulin D Pouthier E Goffin O Devuyst 2000 Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis J Am Soc Nephrol 11 717 28
11. O Devuyst 2002 New insight in the molecular mechanisms regulating peritoneal permeability Nephrol Dial Transplant 17 548 51
12. M Nakayama Y Kawaguchi K Yamada T Hasegawa K Takazoe N Katoh 1997 Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 182 6
13. K Honda K Nitta S Horita W Yumura H Nihei R Nagai 1999 Accumulation of advanced glycation products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultrafiltration failure Nephrol Dial Transplant 14 1541 9
14. S Nakamura T Tachikawa K Tobita S Miyazaki S Sakai T Morita 2003 Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients Am J Kidney Dis 41 S61 7
15. M Nakayama M Ikeda N Katoh H Hayakawa M Numata Y Otuka 2002 Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal (in Japanese) Nippon Jinzo Gakkai Shi (Jpn J Nephrol) 44 396 402
16. R Yamamoto M Nakayama T Hasegawa M Numata H Yamamoto K Yokoyama 2002 High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Adv Perit Dial 18 131 4
17. M Nakayama H Yamamoto M Ikeda T Hasegawa N Kato H Takahashi 2002 Risk factors and preventive measures for encapsulating peritoneal sclerosis - Jikei experience 2002 Adv Perit Dial 18 144 8
18. BJR Junor MA [tmp] McMillan 1993 Immunosuppression in sclerosing peritonitis Adv Perit Dial 9 187 9
19. PM Allaria A Giangrande E Gandini IB Pisoni 1999 Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephol 12 395 7
20. H Suga S Teraoka K Ota S Komemushi S Furutani S Yamauchi 1995 Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats Exp Toxicol Pathol 47 287 91
21. T Sawada Y Ishii T Tojimbara I Nakajima S Fuchinoue S Teraoka 2002 The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice Pharmacol Res 46 505 10
22. S Duman K Wieczorowska-Tobis A Styszynski B Kwiatkowska A Breborowicz DG Oreopoulos 2004 Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum Adv Perit Dial 20 31 6
23. Y Yoshio M Miyazaki K Abe T Nishino A Furusu Y Mizuta 2004 TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model Kidney Int 66 1677 85
24. AI Gunal H Celiker N Akpolat B Ustundag S Duman F Akcicek 2002 By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution Perit Dial Int 22 301 6
25. M Moriishi H Kawanishi T Kawai S Takahashi T Hirai M Shishida 2002 Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis Adv Perit Dial 18 149 53
26. K Kanemaru S Honma Y Okuda H Nozaki S Yanagiba S Miyata 2002 The effect of bicarbonate-buffered physiological saline with heparin on sclerosing peritonitis (in Japanese) Jin To Touseki (Kidney Dial) 53 Suppl 151 3
27. T Tagami S Hara Y Ubara T Yamato T Ose K Nakano 2001 A case report of intra-abdominal lavage after long term CAPD (in Japanese) Jin To Touseki (Kidney Dial) 51 Suppl 54 8
28. E Kurosu S Honma Y Masunaga S Nakano K Nakazawa A Imura 2000 Sclerosing encapsulating peritonitis early diagnosis and management (in Japanese) Jin To Touseki (Kidney Dial) 49 Suppl 333 5